Login / Signup

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors.

Yinghan SuJiang LiWeidan JiGang WangLin FangQin ZhangLin AngMin ZhaoYuan SenLei ChenJunnian ZhengChangqing SuLunxiu Qin
Published in: Journal for immunotherapy of cancer (2022)
The chimeric OncoViron is a novel broad-spectrum anticancer product with multiple mechanisms of synergistic and potentiated immunotherapy, creating a good opportunity for combined immunotherapy against solid tumors.
Keyphrases
  • cell therapy
  • cancer therapy
  • dengue virus
  • mesenchymal stem cells
  • klebsiella pneumoniae
  • escherichia coli
  • zika virus